Source link : https://newshealth.biz/health-news/deupirfenidone-shows-promise-against-ipf-linked-lung-decline/
SAN FRANCISCO — A molecular variant of an older, hard-to-tolerate antifibrotic agent showed promise for reducing decline in forced vital capacity (FVC) over 26 weeks among patients with idiopathic pulmonary fibrosis (IPF). These findings come from the phase 2B ELEVATE IPF trial, results of which were reported at the American Thoracic Society (ATS) 2025 International […]
The post Deupirfenidone Shows Promise Against IPF-Linked Lung Decline first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-28 12:37:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8